Application of stem cell exosome in epidermal injury repair preparation
By using non-pathogenic human Staphylococcus epidermis lysates to stimulate umbilical cord mesenchymal stem cells, improve the secretion amount and repair activity of their exosomes, the problem of poor repair of epidermal lesions in large-area burn trauma treatment was solved, and the problem of poor repair of epidermal lesions was achieved. Significantly shortened healing time and improved healing rate.
Patent Information
- Application Number
- CN202410947848.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art has poor effect on repairing epidermal injury in large-area burn trauma treatment, and the secretion amount and repair activity of stem cell exosomes are low, resulting in poor treatment effect, and stem cell treatment has high cost and risk of inducing tumor formation.
By stimulating the umbilical cord mesenchymal stem cells with non-pathogenic human Staphylococcus epidermis lysates, improving the secretion and repair activity of their exosomes, Staphylococcus epidermis lysates are prepared as biological agents for the preparation of stem cell exosomes. Significantly improve its effect in epidermal injury repair.
It significantly improved the secretion and repair activity of exosomes of umbilical cord mesenchymal stem cells, shortened the healing time of epidermal scalds in mice, and increased the healing rate of wound surfaces. The scab loss time of exosome mice in the exosome group cultured with Staphylococcus epidermal lysate It was 22.78% ahead of the conventional exosome group and significantly improved the injury healing rate.
Smart Images

Figure CN118987038A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biological technology, and in particular relates to an application of stem cell exosomes in an epidermal damage repair preparation. Background Art
[0002] Clinically, many patients with large-area burns and trauma develop hypertrophic scars, which cause appearance deformity and functional impairment. After traditional treatment methods, the body will still be left with scars that cannot be erased for life. Currently, the clinical treatment effect of large-area burns and trauma is still not ideal. Ordinary drugs have poor efficacy in repairing large-area epidermal damage and cannot meet clinical needs.
[0003] Stem cells have become an important breakthrough in the medical field due to their unique self-renewal and multidirectional differentiation capabilities. Pluripotent stem cells, mesenchymal stem cells, epidermal stem cells, and adipose stem cells may all play a promoting role in wound healing. Stem cells have paracrine functions, regulating the state of inflammatory cells and immune microenvironment in specific areas, and the ability to differentiate into blood vessel-related cells. At present, the approval of direct stem cell therapy is still cautious to a certain extent. The birth of pluripotent stem cells has broken through the important ethical barriers to clinical transformation during the embryonic stem cell research period. Its safety has also been recognized to a certain extent, but at this stage, stem cell therapy still has a high cost problem, which is reflected in the cost of stem cell storage and transportation and the risks in the process. The risks of inducing tumors that may arise during the stem cell therapy process also need further research and optimization. In recent years, with the progress of exosome research, the safety of stem cell use has been greatly improved and the application channels of stem cells have been broadened. Exosomes are extracellular lipid nanovesicles with a size of about 30~150nm. They are actively secreted by exocytosis in most living cells and exist in all body fluids, such as plasma, urine, serum, saliva and cerebrospinal fluid. Exosomes contain lipid bilayer membrane structures and carry typical transmembrane proteins and receptors, adhesion molecules, lipid raft-associated proteins, and immunomodulatory molecules. In the exosome cavity, a variety of proteins and nucleic acids can be found, which vary according to different cell types. As key messengers for intercellular communication, exosomes deliver bioactive molecules to receptor cells, thereby participating in a variety of pathological and physiological processes, including tumors, cardiovascular diseases, and neurodegenerative diseases.
[0004] Some research reports also pointed out that among the secretory functions of stem cells, exosomes are one of the main parts that play a major role in paracrine effects. Exosomes have a nanoscale double-layer membrane structure, containing lipids, microRNAs, and proteins that play a key role in intercellular communication. Due to their low immunogenicity and tumorigenicity, as well as their easy storage and management characteristics, exosomes have become a substitute for whole-cell therapy. Umbilical cord mesenchymal stem cell exosomes are expected to play an effective role in the field of epidermal repair, but the low secretion of conventional cultured stem cell exosomes and low epidermal repair activity remain to be solved. Therefore, how to increase the secretion of stem cells and induce stem cells to produce exosomes for epidermal repair is the key to the application of stem cell exosomes in epidermal damage repair preparations. Summary of the invention
[0005] The purpose of the present invention is to provide an application of stem cell exosomes in an epidermal damage repair preparation, thereby utilizing umbilical cord mesenchymal stem cell exosomes to better achieve the effect of epidermal trauma repair.
[0006] To achieve the above object, the present invention provides the following technical solutions: Firstly, the present invention provides an application of stem cell exosomes in an epidermal damage repair preparation, wherein the epidermal damage repair preparation is exosomes produced by umbilical cord mesenchymal stem cells under the stimulation of Staphylococcus epidermidis lysate.
[0007] Furthermore, the method for preparing stem cell exosomes comprises the following steps: (1) Isolation and culture of umbilical cord mesenchymal stem cells; (2) preparing Staphylococcus epidermidis lysate; (3) Umbilical cord mesenchymal stem cells were subcultured into cell culture flasks. The number of subcultures did not exceed 5, and the cell subculture density was 1×10 6 / mL, culture in a carbon dioxide incubator for 24 h until the cell density reaches more than 80%; (4) Add Staphylococcus epidermidis lysate to the cell flask and continue culturing for 24 h. Centrifuge the cell culture supernatant and mix the exosome extraction reagent and cell culture supernatant in a 1:1 ratio. After standing for 16 h, centrifuge at 12,000 rpm for 1 h to collect the precipitate and dissolve the exosomes in PBS with 1 / 10 volume of the original culture medium.
[0008] Furthermore, the dosage of the Staphylococcus epidermidis lysate added to the umbilical cord mesenchymal stem cell culture medium is 100 μg / mL.
[0009] Furthermore, the preparation method of the Staphylococcus epidermidis lysate comprises the following steps: (1) Take non-pathogenic human Staphylococcus epidermidis stored in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate it at 37℃ for 24 hours.
[0010] (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 37°C and 220 rpm / min for 24 hours.
[0011] (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 9 / 10 of the supernatant, and resuspend the bacterial pellet with 1 / 10 of the original volume of the supernatant.
[0012] (4) Disrupt the resuspended bacterial solution using an ultrasonic disruptor, centrifuge at 12,000 rpm / min for 5 min, and collect the supernatant.
[0013] (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus epidermidis lysate. The protein concentration is determined and stored at 4°C for later use.
[0014] Secondly, the present invention provides a biological preparation for increasing the yield of exosomes of umbilical cord mesenchymal stem cells, wherein the biological preparation is a non-pathogenic human Staphylococcus epidermidis lysate.
[0015] Furthermore, the added dosage of the biological agent in the umbilical cord mesenchymal stem cell culture medium is 100 μg / mL.
[0016] Furthermore, the method for preparing the biological agent comprises the following steps: (1) Take non-pathogenic human Staphylococcus epidermidis stored in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate it at 37℃ for 24 hours.
[0017] (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 37°C and 220 rpm / min for 24 hours.
[0018] (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 9 / 10 of the supernatant, and resuspend the bacterial pellet with 1 / 10 of the original volume of the supernatant.
[0019] (4) Disrupt the resuspended bacterial solution using an ultrasonic disruptor, centrifuge at 12,000 rpm / min for 5 min, and collect the supernatant.
[0020] (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus epidermidis lysate. The protein concentration is determined and stored at 4°C for later use.
[0021] The beneficial effects of the present invention are: The present invention prepares Staphylococcus epidermidis lysate by culturing non-pathogenic human Staphylococcus epidermidis, and uses the human Staphylococcus epidermidis lysate to stimulate umbilical cord mesenchymal stem cells to prepare exosomes. Compared with conventionally cultured umbilical cord mesenchymal stem cell exosomes, the use of human Staphylococcus epidermidis lysate stimulation can significantly increase the secretion of umbilical cord mesenchymal stem cell exosomes. When exosomes are used to repair epidermal burns in mice, the same dose of exosomes acts on the burn surface, and the scab shedding time of mice in the exosome group cultured with Staphylococcus epidermidis lysate is 22.78% earlier than that of the conventional exosome group, and the wound healing rate of mice in the exosome group cultured with Staphylococcus epidermidis lysate is significantly higher than that of the conventional exosome group. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 The results of the cytotoxicity test of Staphylococcus epidermidis lysate on umbilical cord mesenchymal stem cells; Figure 2 The grayscale difference of CD36 protein in exosomes of umbilical cord mesenchymal stem cells after culture with different concentrations of Staphylococcus epidermidis lysate; Figure 3 To study the effect of exosomes on the scab shedding time of epidermal wounds in mice; Figure 4 To study the effect of exosomes on the healing rate of epidermal wounds in mice. DETAILED DESCRIPTION
[0023] The following is a more detailed description of the present invention, which is illustrated by examples. It should be clear that these examples are only used as examples of the present invention, and their purpose is to illustrate the principles and functions of the present invention, but not to limit the scope of protection of the present invention.
[0024] Example 1 Isolation and culture of umbilical cord mesenchymal stem cells (1) Obtain an appropriate amount of umbilical cord tissue from full-term newborns using sterile instruments.
[0025] (2) The fresh umbilical cord tissue was transferred into the culture medium containing double antibodies, processed with sterile instruments, and then repeatedly rinsed with PBS for 3 times to wash away blood stains and other foreign matter on the surface.
[0026] (3) Use an appropriate amount of trypsin to digest for about 8 hours and then terminate the digestion. Then transfer the digested cells to a centrifuge tube, add 15 times the volume of PBS and centrifuge. After centrifugation, discard the liquid.
[0027] (4) Add an appropriate amount of mesenchymal stem cell culture medium to resuspend the centrifuged cells, inoculate them into a cell culture bottle, and move them to a carbon dioxide incubator with a CO2 concentration of 5% for culture. Check the adhesion and growth of stem cells every 2 hours. Subsequently, check the cell growth status every 48 hours and replace the culture medium.
[0028] (5) When the cells grow to 80%-90% of the bottom of the bottle, they are subcultured and frozen at the second generation. The stem cells used in this study are from the third to fifth generations.
[0029] Example 2 Preparation of Staphylococcus epidermidis lysate (1) Take non-pathogenic human Staphylococcus epidermidis stored in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate it at 37℃ for 24 hours.
[0030] (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 37°C and 220 rpm / min for 24 hours.
[0031] (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 9 / 10 of the supernatant, and resuspend the bacterial pellet with 1 / 10 of the original volume of the supernatant.
[0032] (4) Disrupt the resuspended bacterial solution using an ultrasonic disruptor, centrifuge at 12,000 rpm / min for 5 min, and collect the supernatant.
[0033] (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus epidermidis lysate. The protein concentration is determined and stored at 4°C for later use.
[0034] Example 3 Detection of the cytotoxicity of Staphylococcus epidermidis lysate on umbilical cord mesenchymal stem cells (1) After the umbilical cord mesenchymal stem cells preserved in the experiment were revived and cultured to the third generation, the cells were digested to prepare a single cell suspension and the cells were inoculated into a 96-well plate and cultured in a carbon dioxide incubator with a CO2 concentration of 5% until the cell density reached more than 80%.
[0035] (2) Use mesenchymal stem cell culture medium to prepare Staphylococcus epidermidis lysate into Staphylococcus epidermidis lysate culture medium with different concentrations: 10 μg / mL, 50 μg / mL, 100 μg / mL, 250 μg / mL and 500 μg / mL.
[0036] (3) Remove the culture medium in the 96-well cell culture plate and replace it with the Staphylococcus epidermidis lysate culture medium in step (2). Replace the control group with the mesenchymal stem cell culture medium.
[0037] (4) After culturing in a cell culture incubator for 24 h, the OD450 value was measured using CCK-8 and the cell survival rate was calculated. Cell survival rate = (OD450 of the experimental group - OD450 of the blank control group) / (OD450nm of the control group - OD450 of the blank control group).
[0038] from Figure 1It can be seen that in the range of 10-250 μg / mL, with the increase of the concentration of S. epidermidis lysate, the cell survival rate of umbilical cord mesenchymal stem cells remained basically stable, and there was no statistically significant difference between the groups. However, the survival rate of umbilical cord mesenchymal stem cells in the 500 μg / mL S. epidermidis lysate group decreased to 83.97%, indicating that the concentration of S. epidermidis lysate in the culture medium reaching 500 μg / mL and above would cause toxicity to umbilical cord mesenchymal stem cells.
[0039] Example 4 Preparation of umbilical cord mesenchymal stem cell exosomes (1) Umbilical cord mesenchymal stem cells were passaged into 75T cell culture flasks, with 30 mL of mesenchymal stem cell serum-free medium per flask and a cell density of 1×10 6 / mL, and cultured in a carbon dioxide incubator with a CO2 concentration of 5% for 24 hours until the cell density reached more than 80%. Groups 1 to 4 were added with 10 μg / mL, 50 μg / mL, 100 μg / mL, and 250 μg / mL of Staphylococcus epidermidis lysate, respectively, and group 5 was a cell control without Staphylococcus epidermidis lysate, with 3 replicates in each group. Continue to culture for 24 hours, collect the cell culture supernatant, and according to the instructions of the exosome extraction kit, mix the exosome extraction reagent and ultrafiltered cell culture supernatant in a ratio of 1:1. After standing for 16 hours, centrifuge at 12000rpm for 1 hour to collect the precipitate, and dissolve the exosomes with 1 / 10 volume of the original culture medium PBS.
[0040] (2) Use RIPA lysis buffer and exosomes in equal volumes, let stand on ice for 1 hour, and shake for 1 to 2 minutes every 10 minutes. Centrifuge at 12000rpm for 15 minutes at 4℃, and collect the supernatant. Mix the sample and 2× Loading buffer at a volume ratio of 1:1, and boil in a water bath for 10 minutes. Perform SDS-PAGE electrophoresis on the prepared sample, transfer to a PVDF membrane, block with 5% skim milk powder solution for 1 hour, use anti-mouse CD63 (ab217345) and GAPDH antibody (ab9485) purchased from Abcam, incubate at 37℃ for 1 hour, rinse 3 times with PBS; use goat anti-rabbit secondary antibody (ab150077) at a dilution of 1:2000, incubate at 37℃ for 1 hour, rinse 3 times with PBS; finally, use ECL luminescent reagent for color development and exposure. Quantity One v462 software was used to analyze the protein gray value and compared with the internal reference protein band to obtain the relative gray ratio. The gray value of the target protein = target protein OD value / corresponding internal reference OD value.
[0041] from Figure 2It can be seen that the amount of exosome marker protein CD63 produced by umbilical cord mesenchymal stem cells cultured in the culture medium with 10 μg / mL, 50 μg / mL, and 100 μg / mL Staphylococcus epidermidis lysate showed a significant increasing trend with the increase of Staphylococcus epidermidis lysate concentration, while there was no statistically significant difference in the amount of exosome marker protein CD63 produced by umbilical cord mesenchymal stem cells cultured in the 100 μg / mL and 250 μg / mL Staphylococcus epidermidis lysate groups.
[0042] Example 5 Effect of umbilical cord mesenchymal stem cell exosomes on epidermal damage repair (1) Forty male ICR mice weighing 20-25 g with intact skin were selected and randomly divided into four groups, with 10 mice in each group.
[0043] (2) After all mice were anesthetized, the hair on their backs was shaved with a shaver, and the depilatory cream was applied to the skin on their backs. After 90 seconds, the depilatory cream was washed off with clean water, and the skin on the backs of the mice was disinfected with iodine cotton balls and alcohol cotton balls.
[0044] (3) Heat a 1.5 cm round weight in a boiling water bath, clamp it with a tweezer and place it on the depilated area on the back of the mouse for 10 seconds to cause skin burns in the mouse. Keep the burn area consistent for each mouse. After the wound model is prepared, the mice are housed in single cages.
[0045] (4) The first group was the burn model group, which did not receive any treatment after the burn; the second group was the culture medium control group, which used a sterile cotton swab to evenly apply the mesenchymal stem cell culture medium to the wound after the burn, once every 12 hours; the third group was the conventional exosome group, which used a sterile cotton swab to evenly apply the exosomes produced by the umbilical cord mesenchymal stem cells without the addition of the Staphylococcus epidermidis lysate in Example 4 to the wound, once every 12 hours; the fourth group was the Staphylococcus epidermidis lysate cultured exosome group, which used a culture medium to dilute the exosomes produced by the umbilical cord mesenchymal stem cells cultured with 100 μg / mL of the Staphylococcus epidermidis lysate in Example 4 to the gray value of the exosome marker protein CD63 to the same gray value as the exosome CD63 of the third group, and evenly applied the exosomes to the wound with a sterile cotton swab, once every 12 hours. The wound healing was observed daily.
[0046] (5) From the beginning of scalding until the scald surface begins to scab and the wound is basically healed, the wound healing time of each group of mice was recorded.
[0047] (6) The scald area of the mice after scalding was recorded on the 5th, 10th and 15th days, and the wound healing rate was calculated. Wound healing rate = (initial wound area - area on the day of measurement) / initial wound area × 100%.
[0048] from Figure 3It can be seen that the average time for the scald surface to heal and scab off in the model group mice was 11.6 days, and the average time for the scab off in the culture medium control group was 11.2 days, with a P value of 0.2457, and the difference was not statistically significant; the average time for the scab off in the conventional exosome group mice was 7.9 days, while the average time for the scab off in the Staphylococcus epidermidis lysate cultured exosome group mice was shortened to 6.1 days, which was 22.78% earlier than that in the conventional exosome group.
[0049] from Figure 4 It can be seen that there was no significant difference in the wound healing rate between the model group and the culture medium control group during the experimental period. On the 14th day, the wound healing rate of the model group was 63.33%, and the wound healing rate of the culture medium control group was 63.80%; the wound healing rate of the conventional exosome group was significantly higher than that of the model group and the culture medium control group, and the wound healing rate of the conventional exosome group was 83.93% on the 14th day; the wound healing rate of the mice in the exosome group cultured with Staphylococcus epidermidis lysate was the highest, with a wound healing rate of 96.47% on the 12th day and a wound healing rate of 96.70% on the 14th day.
[0050] In summary, the amount of exosomes secreted by umbilical cord mesenchymal stem cells cultured with Staphylococcus epidermidis lysate is higher than that secreted by umbilical cord mesenchymal stem cells cultured without Staphylococcus epidermidis lysate. When exosomes were used to repair epidermal burns in mice, the same dose of exosomes acted on the burn surface. The scab shedding time of mice in the exosome group cultured with Staphylococcus epidermidis lysate was 22.78% earlier than that of mice in the conventional exosome group. Moreover, the wound healing rate of mice in the exosome group cultured with Staphylococcus epidermidis lysate was significantly higher than that in the conventional exosome group.
Claims
1. An application of stem cell exosomes in an epidermal damage repair preparation, characterized in that: The epidermal damage repair preparation is exosomes produced by umbilical cord mesenchymal stem cells under the stimulation of Staphylococcus epidermidis lysate.
2. The use according to claim 1, characterized in that: The method for preparing stem cell exosomes comprises the following steps: (1) Isolation and culture of umbilical cord mesenchymal stem cells; (2) preparing Staphylococcus epidermidis lysate; (3) Umbilical cord mesenchymal stem cells were subcultured into cell culture flasks. The number of subcultures did not exceed 5, and the cell subculture density was 1×10 6 / mL, culture in a carbon dioxide incubator for 24 h until the cell density reaches more than 80%; (4) Add Staphylococcus epidermidis lysate to the cell flask and continue culturing for 24 h. Centrifuge the cell culture supernatant and mix the exosome extraction reagent and cell culture supernatant in a 1:1 ratio. After standing for 16 h, centrifuge at 12,000 rpm for 1 h to collect the precipitate and dissolve the exosomes in PBS with 1 / 10 volume of the original culture medium.
3. The Staphylococcus epidermidis lysate according to claim 2, characterized in that The dosage of the Staphylococcus epidermidis lysate added to the umbilical cord mesenchymal stem cell culture medium is 100 μg / mL.
4. The Staphylococcus epidermidis lysate according to claim 3, characterized in that The preparation method of the Staphylococcus epidermidis lysate comprises the following steps: (1) Take non-pathogenic human Staphylococcus epidermidis frozen in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate at 37°C for 24 hours; (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 220 rpm / min at 37°C for 24 hours. (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 9 / 10 of the supernatant, and resuspend the bacterial pellet with 1 / 10 of the original volume of the supernatant; (4) The resuspended bacterial solution was broken by ultrasonic disruptor, centrifuged at 12000 rpm / min for 5 minutes, and the supernatant was collected; (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus epidermidis lysate. The protein concentration is determined and stored at 4°C for later use.
5. A biological preparation for increasing the production of exosomes from umbilical cord mesenchymal stem cells, characterized in that: The biological preparation is a non-pathogenic human Staphylococcus epidermidis lysate.
6. The biological agent according to claim 5, characterized in that The added dosage of the biological preparation in the umbilical cord mesenchymal stem cell culture medium is 100 μg / mL.
7. The biological agent according to claim 6, characterized in that The preparation method of the biological agent comprises the following steps: (1) Take non-pathogenic human Staphylococcus epidermidis frozen in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate at 37°C for 24 hours; (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 220 rpm / min at 37°C for 24 hours. (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 9 / 10 of the supernatant, and resuspend the bacterial pellet with 1 / 10 of the original volume of the supernatant; (4) The resuspended bacterial solution was broken by ultrasonic disruptor, centrifuged at 12000 rpm / min for 5 minutes, and the supernatant was collected; (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus epidermidis lysate. The protein concentration is determined and stored at 4°C for later use.
